1. Home
  2. VYGR vs RXT Comparison

VYGR vs RXT Comparison

Compare VYGR & RXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.89

Market Cap

222.4M

Sector

Health Care

ML Signal

HOLD

Logo Rackspace Technology Inc.

RXT

Rackspace Technology Inc.

HOLD

Current Price

$0.62

Market Cap

250.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYGR
RXT
Founded
2013
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
222.4M
250.9M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
VYGR
RXT
Price
$3.89
$0.62
Analyst Decision
Strong Buy
Hold
Analyst Count
6
6
Target Price
$17.00
$1.61
AVG Volume (30 Days)
667.5K
1.3M
Earning Date
03-10-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$31,316,000.00
$2,688,500,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$71.78
$1.63
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.65
$0.61
52 Week High
$5.78
$3.03

Technical Indicators

Market Signals
Indicator
VYGR
RXT
Relative Strength Index (RSI) 45.43 19.31
Support Level $3.86 $0.61
Resistance Level $4.11 $1.05
Average True Range (ATR) 0.25 0.06
MACD 0.01 -0.03
Stochastic Oscillator 47.79 2.07

Price Performance

Historical Comparison
VYGR
RXT

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About RXT Rackspace Technology Inc.

Rackspace Technology Inc is an end-to-end, hybrid, multi cloud technology services company. It designs, builds and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services; Data; Colocation; Cloud; Managed Hosting; Professional Services; and Security & Compliance. It operates in segments namely, Private Cloud, and Public Cloud. It generates revenue through the sale of consumption-based contracts for its service offerings and from the sale of professional services related to designing and building custom solutions.

Share on Social Networks: